(Q30791071)

26 June 2017

title

The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data (English)

1 reference

Anne-Marie Schjerning Olsen

26 June 2017

1 reference

series ordinal

1

0 references

Gunnar Hilmar Gislason

series ordinal

3

object named as

Gunnar H Gislason

1 reference

26 June 2017

Emil L Fosbøl

2

1 reference

26 June 2017

publication date

25 April 2014

1 reference

Basic and Clinical Pharmacology and Toxicology

26 June 2017

published in

1 reference

26 June 2017

volume

115

1 reference

26 June 2017

issue

2

1 reference

26 June 2017

page(s)

179-184

1 reference

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cyclooxygenase inhibition and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Emotion recollected in tranquility: lessons learned from the COX-2 saga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Prostacyclin protects against elevated blood pressure and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Nonsteroidal anti-inflammatory drugs and cardiovascular risk: is prostacyclin inhibition the key event?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12244

21 January 2018

Identifiers

DOI

10.1111/BCPT.12244

1 reference

26 June 2017

1 reference